Marco Pravetoni

PhD

20022021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 2 Similar Profiles
Oxycodone Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Nicotine Medicine & Life Sciences
Haptens Medicine & Life Sciences
Conjugate Vaccines Medicine & Life Sciences
vaccines Agriculture & Biology
nicotine Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2021

Research Output 2002 2019

6 Citations (Scopus)

A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats

Raleigh, M. D., Baruffaldi, F., Peterson, S. J., Le Naour, M., Harmon, T. M., Vigliaturo, J. R., Pentel, P. R. & Pravetoni, M., Feb 2019, In : Journal of Pharmacology and Experimental Therapeutics. 368, 2, p. 282-291 10 p.

Research output: Contribution to journalArticle

Open Access
Fentanyl
Vaccines
Heroin
Respiratory Insufficiency
Opioid Analgesics
1 Citation (Scopus)
Germinal Center
Opioid Analgesics
Oxycodone
Vaccines
Haptens
1 Citation (Scopus)

Covalent Poly(lactic acid) Nanoparticles for the Sustained Delivery of Naloxone

Kassick, A. J., Allen, H. N., Yerneni, S. S., Pary, F., Kovaliov, M., Cheng, C., Pravetoni, M., Tomycz, N. D., Whiting, D. M., Nelson, T. L., Feasel, M., Campbell, P. G., Kolber, B. & Averick, S., Aug 19 2019, In : ACS Applied Bio Materials. 2, 8, p. 3418-3428 11 p.

Research output: Contribution to journalArticle

Lactic acid
Naloxone
Nanoparticles
Opioid Analgesics
Thioureas

Development of vaccines to treat opioid use disorders and reduce incidence of overdose

Pravetoni, M. & Comer, S. D., Nov 1 2019, In : Neuropharmacology. 158, 107662.

Research output: Contribution to journalReview article

Opioid Analgesics
Vaccines
Incidence
Nicotine
Cocaine
1 Citation (Scopus)

Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation

Baruffaldi, F., Raleigh, M. D., King, S. J., Roslawski, M. J., Birnbaum, A. K., Hassler, C., Carroll, F. I., Runyon, S. P., Winston, S., Pentel, P. R. & Pravetoni, M., Jun 3 2019, In : Molecular Pharmaceutics. 16, 6, p. 2364-2375 12 p.

Research output: Contribution to journalArticle

Conjugate Vaccines
Opioid Analgesics
Oxycodone
Vaccines
Heroin